VAS
Vestmark Advisory Solutions’s Pfizer PFE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-18,724
| Closed | -$474K | – | 803 |
|
2025
Q1 | $474K | Buy |
+18,724
| New | +$474K | 0.01% | 523 |
|
2024
Q4 | – | Sell |
-8,878
| Closed | -$257K | – | 603 |
|
2024
Q3 | $257K | Buy |
+8,878
| New | +$257K | 0.01% | 484 |
|
2023
Q4 | – | Sell |
-37,292
| Closed | -$1.24M | – | 526 |
|
2023
Q3 | $1.24M | Sell |
37,292
-157,193
| -81% | -$5.21M | 0.09% | 220 |
|
2023
Q2 | $7.13M | Sell |
194,485
-2,578
| -1% | -$94.6K | 0.27% | 87 |
|
2023
Q1 | $8.04M | Buy |
197,063
+10,194
| +5% | +$416K | 0.35% | 56 |
|
2022
Q4 | $9.58M | Buy |
186,869
+6,529
| +4% | +$335K | 0.47% | 38 |
|
2022
Q3 | $7.89M | Buy |
180,340
+21,757
| +14% | +$952K | 0.44% | 41 |
|
2022
Q2 | $8.32M | Buy |
158,583
+32,271
| +26% | +$1.69M | 0.47% | 34 |
|
2022
Q1 | $6.54M | Buy |
126,312
+4,304
| +4% | +$223K | 0.37% | 50 |
|
2021
Q4 | $7.21M | Buy |
122,008
+1,510
| +1% | +$89.2K | 0.41% | 44 |
|
2021
Q3 | $5.18M | Buy |
120,498
+10,565
| +10% | +$454K | 0.35% | 63 |
|
2021
Q2 | $4.31M | Sell |
109,933
-5,046
| -4% | -$198K | 0.31% | 73 |
|
2021
Q1 | $4.17M | Sell |
114,979
-14
| -0% | -$507 | 0.37% | 60 |
|
2020
Q4 | $4.23M | Buy |
114,993
+3,719
| +3% | +$137K | 0.48% | 44 |
|
2020
Q3 | $4.08M | Sell |
111,274
-15,212
| -12% | -$558K | 0.55% | 33 |
|
2020
Q2 | $4.14M | Sell |
126,486
-43,343
| -26% | -$1.42M | 0.64% | 29 |
|
2020
Q1 | $5.54M | Buy |
169,829
+7,090
| +4% | +$231K | 1.08% | 13 |
|
2019
Q4 | $6.38M | Buy |
162,739
+5,487
| +3% | +$215K | 1.31% | 13 |
|
2019
Q3 | $5.65M | Buy |
157,252
+13,005
| +9% | +$467K | 0.92% | 15 |
|
2019
Q2 | $6.25M | Sell |
144,247
-13,244
| -8% | -$574K | 1.07% | 10 |
|
2019
Q1 | $6.69M | Buy |
+157,491
| New | +$6.69M | 1.19% | 7 |
|